Dynavax DVAX Stock
Dynavax Price Chart
Dynavax DVAX Financial and Trading Overview
Dynavax stock price | 12.65 USD |
Previous Close | 12.62 USD |
Open | 12.63 USD |
Bid | 0 USD x 3200 |
Ask | 0 USD x 1400 |
Day's Range | 12.58 - 13.03 USD |
52 Week Range | 9.42 - 17.48 USD |
Volume | 2.18M USD |
Avg. Volume | 1.29M USD |
Market Cap | 1.67B USD |
Beta (5Y Monthly) | 1.484507 |
PE Ratio (TTM) | 8.254777 |
EPS (TTM) | 0.2 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 22.8 USD |
DVAX Valuation Measures
Enterprise Value | 1.23B USD |
Trailing P/E | 8.254777 |
Forward P/E | -51.84 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.539928 |
Price/Book (mrq) | 2.9535096 |
Enterprise Value/Revenue | 1.872 |
Enterprise Value/EBITDA | 4.592 |
Trading Information
Dynavax Stock Price History
Beta (5Y Monthly) | 1.484507 |
52-Week Change | 25.70% |
S&P500 52-Week Change | 20.43% |
52 Week High | 17.48 USD |
52 Week Low | 9.42 USD |
50-Day Moving Average | 11.14 USD |
200-Day Moving Average | 11.11 USD |
DVAX Share Statistics
Avg. Volume (3 month) | 1.29M USD |
Avg. Daily Volume (10-Days) | 1.66M USD |
Shares Outstanding | 128.47M |
Float | 121.64M |
Short Ratio | 14.49 |
% Held by Insiders | 0.23% |
% Held by Institutions | 92.94% |
Shares Short | 18.7M |
Short % of Float | 17.78% |
Short % of Shares Outstanding | 14.56% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 35.99% |
Operating Margin (ttm) | 40.18% |
Gross Margin | 61.60% |
EBITDA Margin | 40.77% |
Management Effectiveness
Return on Assets (ttm) | 16.64% |
Return on Equity (ttm) | 55.44% |
Income Statement
Revenue (ttm) | 655.62M USD |
Revenue Per Share (ttm) | 5.15 USD |
Quarterly Revenue Growth (yoy) | -58.79% |
Gross Profit (ttm) | 448.22M USD |
EBITDA | 267.31M USD |
Net Income Avi to Common (ttm) | 235.81M USD |
Diluted EPS (ttm) | 1.57 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 651.96M USD |
Total Cash Per Share (mrq) | 5.07 USD |
Total Debt (mrq) | 257.82M USD |
Total Debt/Equity (mrq) | 45.73 USD |
Current Ratio (mrq) | 9.071 |
Book Value Per Share (mrq) | 4.388 |
Cash Flow Statement
Operating Cash Flow (ttm) | 140.78M USD |
Levered Free Cash Flow (ttm) | 78.86M USD |
Profile of Dynavax
Country | United States |
State | CA |
City | EmeryVille |
Address | 2100 Powell Street |
ZIP | 94608 |
Phone | 510 848 5100 |
Website | https://www.dynavax.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 351 |
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Q&A For Dynavax Stock
What is a current DVAX stock price?
Dynavax DVAX stock price today per share is 12.65 USD.
How to purchase Dynavax stock?
You can buy DVAX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dynavax?
The stock symbol or ticker of Dynavax is DVAX.
Which industry does the Dynavax company belong to?
The Dynavax industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dynavax have in circulation?
The max supply of Dynavax shares is 124.07M.
What is Dynavax Price to Earnings Ratio (PE Ratio)?
Dynavax PE Ratio is 63.24999600 now.
What was Dynavax earnings per share over the trailing 12 months (TTM)?
Dynavax EPS is 0.2 USD over the trailing 12 months.
Which sector does the Dynavax company belong to?
The Dynavax sector is Healthcare.
Dynavax DVAX included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
NASDAQ Capital Market Composite RCMP | 92.16 USD — |
-4.45
|
— — | 89.57 USD — | 93.85 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
NASDAQ Composite Total Return I XCMP | 19079.55 USD — |
-5.82
|
— — | 19064.73 USD — | 19740.96 USD — | — - | — — |
Nasdaq US 700 Small Cap Index NQUS700SC | 1938.96 USD — |
-4.51
|
— — | 1891.68 USD — | 1965.66 USD — | — - | — — |
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2500.59 USD — |
-5.81
|
— — | 2469.29 USD — | 2585.45 USD — | — - | — — |
NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}